Search

everythinglearnresearchcommunity

for

Search:↓

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

PRFM may help treat hair loss, especially in mild cases.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Biologicals are increasingly used in medicine and cosmetics, especially for skin and hair treatments, but more research is needed.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Bempikibart may help regrow hair in people with alopecia areata.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

Higher activity in lichen planopilaris is linked to certain immune and tissue genes.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Presurgical models can effectively and affordably screen cancer prevention agents.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

Higher levels of miR-1199-5p may reduce the effectiveness of certain prostate treatments.

Research on non-muscle invasive bladder cancer has increased, with the U.S. leading, and highlights effective treatments like BCG despite some side effects.

A man with alopecia universalis regrew hair temporarily after a bone treatment.

New biological pathways and potential treatment targets for male pattern baldness were identified.

The document concludes that a protein involved in hair growth may link to baldness and that more research is needed on its role in hair loss and skin cancer treatments.

Adding Baricitinib for severe alopecia areata will have a small impact on a health plan's budget.

UVB radiation changes the levels of certain microRNAs in skin cells, which may affect cell survival and hair growth.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Hydroxypinacolone retinoate is a potent anti-aging ingredient for skin that is more effective and less irritating than other forms of retinoids.

Women with idiopathic hirsutism and PCOS have higher RBP4 levels, and PCOS is linked to greater insulin resistance; weight management may help both conditions.

A rare skin condition in a 17-year-old was diagnosed late, stressing the need for careful evaluation and genetic testing.

Natural gene therapy shows promise for treating skin disorders like epidermolysis bullosa.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Combining light therapy and microneedling shows promise for treating female hair loss.

A low-cost, 3D-printed light therapy device is safe and effective but needs more testing before use on people.

Certain genetic variations in the RAB5B gene are linked to a higher risk of polycystic ovary syndrome in Chinese Han women.

Vemurafenib causes significant skin side effects, requiring regular dermatologist care and sun protection.